Debt-to-equity in % of COGNITION THERAPEUTICS INC from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cognition Therapeutics Inc quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2025.
  • Cognition Therapeutics Inc Debt-to-equity for the quarter ending September 30, 2025 was 56.6 %, a 13.8% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)

COGNITION THERAPEUTICS INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 56.6 +6.85 +13.8% Sep 30, 2025
Q2 2025 92.1 +52.4 +132% Jun 30, 2025
Q1 2025 68.9 +34.5 +100% Mar 31, 2025
Q4 2024 54 +21.6 +66.8% Dec 31, 2024
Q3 2024 49.7 +21.4 +75.4% Sep 30, 2024
Q2 2024 39.8 +10.5 +35.8% Jun 30, 2024
Q1 2024 34.4 +7.25 +26.7% Mar 31, 2024
Q4 2023 32.4 +7.23 +28.8% Dec 31, 2023
Q3 2023 28.3 +5.97 +26.7% Sep 30, 2023
Q2 2023 29.3 -44.3 -60.2% Jun 30, 2023
Q1 2023 27.1 Mar 31, 2023
Q4 2022 25.1 Dec 31, 2022
Q3 2022 22.4 Sep 30, 2022
Q2 2022 73.6 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.